14.11.2017

MagForce AG to participate at SNO 2017 Annual Meeting from November 16-19 in San Francisco, USA

Berlin, Germany, and Nevada, USA, November 14, 2017 - MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced its participation in the 22nd Annual Scientific Meeting and Education Day of the ...

 

27.10.2017

MagForce AG publishes Directors' Dealings

download PDF

 

29.09.2017

MagForce AG Publishes Financial Results for the First Half of 2017 and Operative Highlights

Berlin, Germany, and Nevada, USA, September 29, 2017 - MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results for the first half of 2017, ending on June 30, 2017, and ...

 

05.09.2017

MagForce AG to participate in seven upcoming international conferences in H2/2017

Berlin, Germany and Nevada, USA, September 05, 2017 - MagForce AG (Frankfurt, Scale, Xetra: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced its participation in seven upcoming scientific and investor conferences in the ...

 

16.08.2017

MagForce AG publishes Directors' Dealings

download PDF